249 related articles for article (PubMed ID: 26367865)
1. Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety.
Johnson JL; Kwok YH; Sumracki NM; Swift JE; Hutchinson MR; Johnson K; Williams DB; Tuke J; Rolan PE
Headache; 2015 Oct; 55(9):1192-208. PubMed ID: 26367865
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine.
Kwok YH; Swift JE; Gazerani P; Rolan P
J Pain Res; 2016; 9():899-907. PubMed ID: 27826212
[TBL] [Abstract][Full Text] [Related]
3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind clinical trial.
Taghdiri F; Togha M; Razeghi Jahromi S; Paknejad SM
Headache; 2015 Jan; 55(1):128-35. PubMed ID: 25600720
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
[TBL] [Abstract][Full Text] [Related]
6. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers.
Cooper ZD; Johnson KW; Pavlicova M; Glass A; Vosburg SK; Sullivan MA; Manubay JM; Martinez DM; Jones JD; Saccone PA; Comer SD
Addict Biol; 2016 Jul; 21(4):895-903. PubMed ID: 25975386
[TBL] [Abstract][Full Text] [Related]
7. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study.
Rabe K; Pageler L; Gaul C; Lampl C; Kraya T; Foerderreuther S; Diener HC; Katsarava Z
Cephalalgia; 2013 Feb; 33(3):202-7. PubMed ID: 23093541
[TBL] [Abstract][Full Text] [Related]
8. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.
Cooper ZD; Johnson KW; Vosburg SK; Sullivan MA; Manubay J; Martinez D; Jones JD; Saccone PA; Comer SD
Drug Alcohol Depend; 2017 Sep; 178():340-347. PubMed ID: 28688296
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
Diener HC; Marmura MJ; Tepper SJ; Cowan R; Starling AJ; Diamond ML; Hirman J; Mehta L; Brevig T; Sperling B; Cady R
Headache; 2021 Jan; 61(1):125-136. PubMed ID: 33314079
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
11. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study.
Bøe MG; Mygland A; Salvesen R
Neurology; 2007 Jul; 69(1):26-31. PubMed ID: 17475943
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
13. Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence.
Metz VE; Jones JD; Manubay J; Sullivan MA; Mogali S; Segoshi A; Madera G; Johnson KW; Comer SD
Neuropsychopharmacology; 2017 Aug; 42(9):1825-1832. PubMed ID: 28393896
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.
Yu S; Zhou J; Luo G; Xiao Z; Ettrup A; Jansson G; Florea I; Ranc K; Pozo-Rosich P
BMC Neurol; 2023 Dec; 23(1):441. PubMed ID: 38102535
[TBL] [Abstract][Full Text] [Related]
15. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.
Pini LA; Guerzoni S; Cainazzo MM; Ferrari A; Sarchielli P; Tiraferri I; Ciccarese M; Zappaterra M
J Headache Pain; 2012 Nov; 13(8):677-84. PubMed ID: 23070400
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
17. Treatment of withdrawal headache in patients with medication overuse headache: a pilot study.
Cevoli S; Giannini G; Favoni V; Terlizzi R; Sancisi E; Nicodemo M; Zanigni S; Bacchi Reggiani ML; Pierangeli G; Cortelli P
J Headache Pain; 2017 Dec; 18(1):56. PubMed ID: 28500492
[TBL] [Abstract][Full Text] [Related]
18. Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment.
Johnson JL; Hutchinson MR; Williams DB; Rolan P
Cephalalgia; 2013 Jan; 33(1):52-64. PubMed ID: 23144180
[TBL] [Abstract][Full Text] [Related]
19. Prednisone vs. placebo in withdrawal therapy following medication overuse headache.
Pageler L; Katsarava Z; Diener HC; Limmroth V
Cephalalgia; 2008 Feb; 28(2):152-6. PubMed ID: 18039339
[TBL] [Abstract][Full Text] [Related]
20. Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.
Starling AJ; Cowan RP; Buse DC; Diener HC; Marmura MJ; Hirman J; Brevig T; Cady R
Headache; 2023 Feb; 63(2):264-274. PubMed ID: 36633219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
